Master10 Proprietary Question Bank - Automated scraping, spidering, or harvesting is strictly prohibited.
Public Health, Nutrition & Epidemics25 Essential Exam Concepts
World Patient Safety Day: Safe Care for Noncommunicable Diseases & Polypharmacy
World Patient Safety Day is observed internationally every year on 17 September to enhance global awareness of clinical safety, minimize avoidable healthcare-associated harm, and mobilize systemic action across clinical institutions. The observance was formally instituted in May 2019 by the 72nd World Health Assembly through Resolution WHA 72.6, titled Global Action on Patient Safety. The campaign is recognized visually by illuminating iconic monuments and medical facilities in orange, the designated international color representing patient safety. The overarching strategic framework is guided by the World Health Organization Global Patient Safety Action Plan 2021 to 2030, which sets an operational roadmap to achieve zero avoidable patient harm through strong clinical governance and transparent reporting systems.
The focus on safe clinical care for noncommunicable diseases addresses one of modern medicine's greatest structural vulnerabilities. Noncommunicable diseases—primarily cardiovascular diseases, diabetes mellitus, chronic respiratory disorders, and cancers—account for approximately seventy-four percent of all global mortalities. Managing these chronic conditions requires lifelong, multi-drug therapies, commonly resulting in polypharmacy, where patients take five or more prescription medications concurrently. Polypharmacy multiplies the risk of severe adverse drug events, hazardous drug-drug interactions, accidental overdosing, and renal or hepatic toxicity. Clinical harm also arises from diagnostic misclassification, delayed specialist referrals, dosage titration errors during insulin or anticoagulant administration, and fragmented communication between primary clinics and tertiary hospitals.
In competitive examinations, patient safety in chronic disease management represents a major subject within health governance, clinical quality standards, and healthcare expenditure analysis. Unsafe medical practices impose catastrophic financial costs on families and drain public healthcare budgets through extended hospital stays and emergency readmissions. Addressing these risks requires systematic implementation of medication reconciliation at every care transition, digital electronic health record interoperability, robust national pharmacovigilance networks, and patient education programs. In India, these standards are reinforced by the National Patient Safety Implementation Framework and hospital accreditation protocols administered by the National Accreditation Board for Hospitals and Healthcare Providers.
High-yield conceptual summaries for competitive exams and rapid revision.
World Patient Safety Day is observed globally every year on 17 September, established by the 72nd World Health Assembly in May 2019 via Resolution WHA 72.6.
The signature visual campaign of World Patient Safety Day involves illuminating public monuments and medical centres in orange light.
The WHO Global Patient Safety Action Plan 2021–2030 establishes the strategic objective of eliminating avoidable healthcare harm worldwide.
Noncommunicable diseases account for roughly 41 million deaths each year, equivalent to 74 percent of all global deaths according to WHO data.
Polypharmacy is clinically defined as the routine concurrent use of five or more prescribed medications by a single patient.
Medication Without Harm is the Third WHO Global Patient Safety Challenge, targeting a 50 percent reduction in severe avoidable medication-related harm.
Cardiovascular diseases constitute the single largest contributor to noncommunicable disease mortality, causing an estimated 17.9 million deaths annually.
Adverse Drug Events (ADEs) represent injuries resulting from medical interventions related to drugs, encompassing adverse drug reactions and medication errors.
Medication reconciliation is the standardized clinical process of compiling a complete, accurate list of a patient’s current medications across care transitions.
In India, the Pharmacovigilance Programme of India (PvPI), coordinated by the Indian Pharmacopoeia Commission in Ghaziabad, monitors adverse drug reactions.
The National Accreditation Board for Hospitals and Healthcare Providers (NABH), a constituent board of the Quality Council of India, sets national patient safety standards.
Narrow therapeutic index drugs used in chronic care, such as warfarin, digoxin, and lithium, require regular plasma monitoring to avoid clinical toxicity.
Diagnostic errors in chronic disease management contribute significantly to delayed cancer staging, inappropriate chemotherapy, and preventable ischemic tissue loss.
The National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD) in India targets early screening at Ayushman Arogya Mandirs.
Clean Care is Safer Care was the First WHO Global Patient Safety Challenge, dedicated to reducing healthcare-associated infections through hand hygiene.
Safe Surgery Saves Lives was the Second WHO Global Patient Safety Challenge, which introduced the standardized 19-item Surgical Safety Checklist.
WHO estimates that globally, four out of ten patients experience harm in primary and ambulatory healthcare settings, with up to 80 percent being preventable.
Beers Criteria, published by the American Geriatrics Society, lists potentially inappropriate medications that pose high risks for older adults with chronic ailments.
Electronic prescription systems with clinical decision support reduce transcription errors and automatically alert physicians to harmful drug-drug interactions.
Under Sustainable Development Goal Target 3.4, nations committed to reducing premature mortality from noncommunicable diseases by one-third by 2030.
Search across all 0 What Is World Patient Safety Day 2026 and Why Is Safe Care for Noncommunicable Diseases Important? questions or browse 52,789+ verified questions across 65 domains.